HeartSciences (HSCS) Return on Capital Employed (2022 - 2025)
HeartSciences (HSCS) posted quarterly Return on Capital Employed of 177.18% for Q4 2025, down 1771.0% year-on-year from 10.6% in Q4 2024, and up 49.67% on a QoQ basis from 352.01% in Q3 2025.
HeartSciences (HSCS) Return on Capital Employed (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has reported Return on Capital Employed for 4 consecutive years, with 177.18% the latest figure, recorded in Q4 2025.
- Quarterly Return on Capital Employed fell 1771.0% year-over-year to 177.18% in Q4 2025, while the trailing twelve-month figure through Oct 2025 was 177.18% (down 1771.0% YoY) and the FY2025 annual result came in at 264.34%, down 12854.0% from the prior year.
- Return on Capital Employed improved to 177.18% in Q4 2025 per HSCS's latest filing, from 352.01% in the prior quarter.
- Over the last five years, Return on Capital Employed for HSCS reached as high as 554.21% in Q4 2023 and fell as low as 662.81% in Q2 2025.
- A 4-year average of 226.7% and a median of 250.65% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 86370 bps — and 2024, when it plunged 71368 bps.
- Year by year, Return on Capital Employed stood at 309.49% in 2022, then soared by 279 bps to 554.21% in 2023, then plunged by 129 bps to 159.47% in 2024, then dropped by 11 bps to 177.18% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 177.18%, 352.01%, and 662.81% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -177.18% |
| Jul 31, 2025 | -352.01% |
| Apr 30, 2025 | -662.81% |
| Jan 31, 2025 | -262.27% |
| Oct 31, 2024 | -159.47% |
| Jul 31, 2024 | -94.07% |
| Apr 30, 2024 | -75.07% |
| Jan 31, 2024 | -123.49% |
| Oct 31, 2023 | 554.21% |
| Jul 31, 2023 | -575.60% |
| Apr 30, 2023 | -394.16% |
| Jan 31, 2023 | -303.36% |
| Oct 31, 2022 | -309.49% |
| Jul 31, 2022 | -239.03% |